Category: Investor Corner

Group 1000001206

Sen-Jam Pharmaceutical Joins Forces with The Global Passion Project for Transfor...

HUNTINGTON, N.Y., April 1, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is proud to sponsor and participate in The Global Passion Project’s upcoming Healthcare Investor Summit, taking place…
Read More
Group 1000001207 (1)

Behind the Breakthrough: Strategic Insights from Sen-Jam’s Executive Leade...

In March 2025, Sen-Jam Pharmaceutical hosted a pivotal webinar in collaboration with Destum Partners, a premier strategic advisory firm known for driving success in biotech partnerships, licensing, and M&A…
Read More
Mask Group (20)

Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C

One year ago, we filed a provisional patent application for our Upper Respiratory Infection Therapeutic – SJP-002C, covering the novel manufacturing process for our dual-acting oral therapy…
Read More
Compressed Mask Group 16

Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships ...

HUNTINGTON, N.Y., Feb. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a pioneering biotech company dedicated to innovative anti-inflammatory solutions, is pleased to announce its engagement…
Read More
Compressed Mask Group 21

Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizon...

HUNTINGTON, N.Y., Jan. 22, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative solutions targeting inflammation and metabolic health, proudly announces a financial and strategic…
Read More

Where the Next Spark Becomes Tomorrow’s Headline

 

Our newsroom of scientists, strategists, and culture-watchers tracks the earliest pulses in biology, policy, and public conversation—translating fresh data into actionable perspective before the rest of pharma blinks. Stay tuned, stay sharp, and stay upstream with us.

Subscribe for Fresh Signals
MEDIA INQUIRIES

Media Inquiry